memantine has been researched along with Hebephrenic Schizophrenia in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
" The duration of the study for each patient was 6 months, the target dosage of acatinol was 20 mg." | 2.79 | [The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features]. ( Arsenieva, TB; Beniashvili, AG; Burminsky, DS; Cheremin, RA; Kozhekin, IG; Lepilkina, TA; Morozova, MA; Onegina, EY; Potanin, SS; Rupchev, GE; Shvedova, AK; Yachmenev, VN, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morozova, MA | 1 |
Rupchev, GE | 1 |
Kozhekin, IG | 1 |
Arsenieva, TB | 1 |
Cheremin, RA | 1 |
Yachmenev, VN | 1 |
Onegina, EY | 1 |
Shvedova, AK | 1 |
Beniashvili, AG | 1 |
Burminsky, DS | 1 |
Lepilkina, TA | 1 |
Potanin, SS | 1 |
1 trial available for memantine and Hebephrenic Schizophrenia
Article | Year |
---|---|
[The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features].
Topics: Adult; Antipsychotic Agents; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Schizoph | 2014 |